spacer
home > epc > Summer 2019
PUBLICATIONS

European Pharmaceutical Contractor

epc
Summer 2019

   
Text
PDF
bullet
Clinical data
Clinical Trial Data Capture

The Changing Face of Clinical Data

Clinical data can take many forms, and the way we collect and analyse these data is evolving, explains Aiden Flynn at Exploristics.
 
view
download pdf
Clinical Trial Sponsors

Preparations for the New EU Portal

Thomas Wicks at Trialscope explores the ways in which clinical trials in the EU will be forced to change when new regulations come into play, and how organisations should prepare for these changes.
 
view
download pdf
Real-World Evidence in Drug Development

Fit for Purpose

IQVIA Biotech’s Marni Hall and Nicola Stanislaus evaluate the framework of real-world evidence application in clinical trials and the coordinated efforts of pharmaceutical companies and regulatory bodies.
 
view
download pdf
From EDC to eSource

Overcoming the Industry's Data Crisis

With an industry-wide aim for improved data collection, Ed Seguine at Clinical Ink discusses the current view that pharma is locked in an innovation paradox.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

PCI Strengthens Position in Europe with Investment in Ireland

Philadelphia, PA – August 27, 2019 – PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and expand its European foothold.
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement